Dominique Costagliola
#58,771
Most Influential Person Now
French epidemiologist
Dominique Costagliola's AcademicInfluence.com Rankings
Dominique Costagliolamedical Degrees
Medical
#618
World Rank
#827
Historical Rank
Epidemiology
#147
World Rank
#159
Historical Rank
Download Badge
Medical
Why Is Dominique Costagliola Influential?
(Suggest an Edit or Addition)According to Wikipedia, Dominique Costagliola is a French epidemiologist and biostatistician, deputy director of the Pierre Louis Institute of Epidemiology and Public Health and is considered a “leading AIDS specialist.”,
Dominique Costagliola's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies (2002) (1630)
- Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study (2013) (895)
- Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies (2009) (806)
- Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover (2007) (747)
- Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. (2010) (577)
- Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men (2003) (575)
- Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. (2009) (531)
- Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. (2005) (453)
- Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy (2000) (428)
- The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals (2010) (413)
- Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. (2004) (375)
- Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. (2001) (363)
- Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic) (2008) (354)
- Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. (2000) (342)
- Polylactic acid implants (New-Fill)® to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA (2003) (334)
- Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. (2003) (334)
- Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. (2005) (331)
- Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4. (2010) (322)
- Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE) (2013) (321)
- Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies (2007) (315)
- Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population (2010) (293)
- Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial (2002) (274)
- Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies (2003) (268)
- Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy (2008) (266)
- Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group. (1995) (261)
- Comparison of dynamic treatment regimes via inverse probability weighting. (2006) (254)
- HIV and coronary heart disease: time for a better understanding. (2013) (251)
- When to Initiate Combined Antiretroviral Therapy to Reduce Mortality and AIDS-Defining Illness in HIV-Infected Persons in Developed Countries (2011) (242)
- Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients. (2009) (238)
- Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy (2009) (238)
- HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis (2006) (235)
- Beyond viral suppression of HIV – the new quality of life frontier (2016) (227)
- Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. (1999) (224)
- Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000 (2014) (220)
- Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America (2015) (217)
- Early regression of cervical lesions in HIV‐seropositive women receiving highly active antiretroviral therapy (1998) (212)
- Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV (2004) (210)
- Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. (2009) (200)
- Insulinemic and glycemic indexes of six starch-rich foods taken alone and in a mixed meal by type 2 diabetics. (1987) (193)
- Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. (2006) (189)
- Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV (2009) (186)
- When to Start Treatment? A Systematic Approach to the Comparison of Dynamic Regimes Using Observational Data (2010) (185)
- Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor (2000) (177)
- Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey. (2009) (173)
- Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial (2021) (168)
- Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial (2021) (168)
- Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir (2008) (159)
- HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis. (2011) (158)
- Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV. (2012) (155)
- HIV infection in older patients in the HAART era. (2006) (154)
- Frequency, determinants and consequences of delayed access to care for HIV infection in France (2007) (151)
- Immunodeficiency at the Start of Combination Antiretroviral Therapy in Low-, Middle-, and High-Income Countries (2013) (149)
- Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients (2011) (149)
- Semen alterations in HIV-1 infected men. (2002) (147)
- HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals. (2012) (146)
- Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups. (1999) (143)
- French National Sentinel Survey of Antiretroviral Drug Resistance in Patients With HIV-1 Primary Infection and in Antiretroviral-Naive Chronically Infected Patients in 2001-2002 (2005) (142)
- Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach (2009) (141)
- A routine tool for detection and assessment of epidemics of influenza-like syndromes in France. (1991) (135)
- Evaluation of a peer support group therapy for HIV-infected adolescents (2005) (130)
- Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France (2003) (126)
- Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease (2005) (124)
- Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression. (2005) (123)
- Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study. (2009) (121)
- Routine HIV Screening in France: Clinical Impact and Cost-Effectiveness (2010) (121)
- Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era. (2001) (119)
- AIDS-related malignancies: state of the art and therapeutic challenges. (2008) (119)
- A therapeutic dendritic cell-based vaccine for HIV-1 infection. (2011) (116)
- Kaposi Sarcoma Incidence and Survival Among HIV-Infected Homosexual Men After HIV Seroconversion (2010) (115)
- The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes (2006) (115)
- Development and Validation of an Immunoassay for Identification of Recent Human Immunodeficiency Virus Type 1 Infections and Its Use on Dried Serum Spots (2005) (115)
- Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies (2014) (115)
- Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis. (2011) (114)
- Epidemiology of toxoplasmosis among pregnant women in the Paris area. (1988) (112)
- Skin cancers associated with HIV infection and solid‐organ transplantation among elderly adults (2010) (111)
- SUCROSE TAKEN DURING MIXED MEAL HAS NO ADDITIONAL HYPERGLYCAEMIC ACTION OVER ISOCALORIC AMOUNTS OF STARCH IN WELL-CONTROLLED DIABETICS (1984) (110)
- Genotypic Inhibitory Quotient as Predictor of Virological Response to Ritonavir-Amprenavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients (2003) (106)
- Liver‐related deaths in HIV‐infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 Study in collaboration with the Mortalité 2005 survey, ANRS EN19) * (2009) (102)
- Transcutaneous Anti-Influenza Vaccination Promotes Both CD4 and CD8 T Cell Immune Responses in Humans1 (2008) (100)
- The spectrum of malignancies in HIV‐infected patients in 2006 in France: The ONCOVIH study (2011) (98)
- Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort. (2013) (98)
- Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV. (1999) (97)
- Incidence and Risk Factors of HIV-Related Non-Hodgkin's Lymphoma in the era of Combination Antiretroviral Therapy: A European Multicohort Study (2009) (97)
- Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions (2014) (96)
- Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs (2018) (96)
- Preferential Amplification of CD8 Effector-T Cells after Transcutaneous Application of an Inactivated Influenza Vaccine: A Randomized Phase I Trial (2010) (96)
- Risk of triple-class virological failure in children with HIV: a retrospective cohort study (2011) (95)
- Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection (2002) (93)
- Effect of early syphilis infection on plasma viral load and CD4 cell count in human immunodeficiency virus-infected men: results from the FHDH-ANRS CO4 cohort. (2012) (92)
- Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452) (2008) (92)
- Predictors identified for losses to follow-up among HIV-seropositive patients. (2006) (92)
- Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients (2000) (91)
- Malignancy‐related causes of death in human immunodeficiency virus–infected patients in the era of highly active antiretroviral therapy (2004) (91)
- Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097) (2004) (91)
- Demographics of HIV and aging. (2014) (88)
- Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996–2006 in France (2009) (88)
- Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial (2010) (87)
- Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002–2009 (2012) (86)
- HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression. (2001) (86)
- The undiagnosed HIV epidemic in France and its implications for HIV screening strategies (2014) (85)
- Patterns of disclosure and perceptions of the human immunodeficiency virus in infected elementary school-age children. (1997) (85)
- INTERLEUKIN-2 ACCELERATES CD4 CELL RECONSTITUTION IN HIV-INFECTED PATIENTS WITH SEVERE IMMUNOSUPPRESSION DESPITE HIGHLY ACTIVE ANTIRETROVIRAL THERAPY: THE ILSTIM STUDY—ANRS 082 (2002) (84)
- Cancer-Related Causes of Death among HIV-Infected Patients in France in 2010: Evolution since 2000 (2015) (84)
- Incubation period of Creutzfeldt–Jakob disease in human growth hormone recipients in France (1999) (84)
- Causes of the first AIDS‐defining illness and subsequent survival before and after the advent of combined antiretroviral therapy * (2008) (83)
- Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy (2000) (82)
- Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity (2006) (81)
- Effect of Pioglitazone on HIV-1-Related Lipodystrophy: A Randomized Double-Blind Placebo-Controlled Trial (ANRS 113) (2008) (78)
- Observation plans in longitudinal studies with time-varying treatments (2009) (78)
- Liver‐related deaths in HIV‐infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey (2015) (75)
- Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France (2005) (74)
- Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4). (2014) (74)
- Clinically relevant interpretation of genotype for resistance to abacavir (2003) (73)
- Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France. (2010) (73)
- Do Tests Devised to Detect Recent HIV-1 Infection Provide Reliable Estimates of Incidence in Africa? (2007) (72)
- Effect estimates in randomized trials and observational studies: comparing apples with apples. (2019) (72)
- Drug interactions between antineoplastic and antiretroviral therapies: Implications and management for clinical practice. (2009) (71)
- Clinically Validated Genotype Analysis: Guiding Principles and Statistical Concerns (2004) (70)
- Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir (2016) (70)
- Timing of mother‐to‐child HIV‐1 transmission depends on maternal status (1993) (69)
- Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy (2009) (69)
- GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy * (2004) (69)
- High Rate of Recurrence of Cervical Intraepithelial Neoplasia After Surgery in HIV-Positive Women (2005) (69)
- Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus. (2002) (69)
- Serum ferritin, desferrioxamine, and evolution of HIV-1 infection in thalassemic patients. (1998) (69)
- Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC). (2014) (68)
- Status of long‐term asymptomatic HIV‐1 infection correlates with viral load but not with virus replication properties and cell tropism (1999) (68)
- What is known about the prevention of congenital toxoplasmosis? (1990) (67)
- Comparing the public health burden of chronic hepatitis C and HIV infection in France. (2004) (66)
- Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. (2015) (66)
- Predictors of the Virological Response to a Change in the Antiretroviral Treatment Regimen in HIV-1-Infected Patients Enrolled in a Randomized Trial Comparing Genotyping, Phenotyping and Standard of Care (Narval Trial, Anrs 088) (2002) (66)
- Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. (2012) (63)
- Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression. (2016) (63)
- Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patients. (2007) (63)
- Prevalence of HIV-1 Drug Resistance in Treated Patients: A French Nationwide Study (2007) (63)
- A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control (2015) (62)
- Risk factors for osteonecrosis in HIV-infected patients: impact of treatment with combination antiretroviral therapy (2006) (62)
- CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC) (2017) (61)
- CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC) (2017) (61)
- New method for estimating HIV incidence and time from infection to diagnosis using HIV surveillance data: results for France (2011) (60)
- Improved Survival of HIV-1-Infected Patients with Progressive Multifocal Leukoencephalopathy Receiving Early 5-Drug Combination Antiretroviral Therapy (2011) (60)
- Progression to AIDS in French haemophiliacs: association with HLA-B35. (1993) (59)
- A prospective evaluation of clinical criteria and polymerase chain reaction assay of cerebrospinal fluid for the diagnosis of cytomegalovirus‐related neurological diseases during AIDS (1995) (59)
- Timing of mother-to-child HIV-1 transmission and diagnosis of infection based on polymerase chain reaction in the neonatal period by a non-parametric method. (1997) (58)
- Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement. (2006) (58)
- Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study (2014) (57)
- Dose of desferrioxamine and evolution of HIV‐1 infection in thalassaemic patients (1994) (57)
- Impact of Late Presentation on the Risk of Death Among HIV-Infected People in France (2003–2009) (2013) (57)
- Effects of type of smoking (pipe, cigars or cigarettes) on biological indices of tobacco exposure and toxicity. (2006) (55)
- Repeated HIV‐1 resistance genotyping external quality assessments improve virology laboratory performance (2006) (55)
- Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication (2005) (55)
- Sucrose or honey at breakfast have no additional acute hyperglycaemic effect over an isoglucidic amount of bread in Type 2 diabetic patients (1985) (55)
- Relationship between Regulatory T Cells and Immune Activation in Human Immunodeficiency Virus-Infected Patients Interrupting Antiretroviral Therapy (2010) (55)
- National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011. (2013) (54)
- HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy. (2011) (53)
- Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial (2016) (53)
- Efficacy and Tolerability of Stavudine plus Lamivudine in Treatment-Naive and Treatment-Experienced Patients with HIV-1 Infection (1998) (53)
- Clinically Relevant Interpretation of Genotype and Relationship to Plasma Drug Concentrations for Resistance to Saquinavir-Ritonavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients (2004) (53)
- An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 (2021) (52)
- Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094). (2005) (51)
- Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study. (2009) (51)
- Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study. (2015) (51)
- Record-linkage between two anonymous databases for a capture-recapture estimation of underreporting of AIDS cases: France 1990-1993. The Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodéficience Humaine. (2000) (50)
- Impact of Stavudine Phenotype and Thymidine Analogues Mutations on Viral Response to Stavudine plus Lamivudine in Altis 2 Anrs Trial (2001) (50)
- Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era (2017) (50)
- Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy (2010) (49)
- Abacavir and Cardiovascular Risk: Reviewing the Evidence (2010) (49)
- Primary Prevention With Cotrimoxazole for HIV‐1‐Infected Adults: Results of the Pilot Study in Dakar, Senegal (2001) (48)
- HIV in hiding: methods and data requirements for the estimation of the number of people living with undiagnosed HIV. (2011) (48)
- 'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study. (2001) (47)
- The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and Challenges (2017) (47)
- High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy. (1998) (46)
- No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients (2005) (46)
- Decreased prevalence of intestinal cryptosporidiosis in HIV-infected patients concomitant to the widespread use of protease inhibitors. (1998) (46)
- Resistance-Associated Mutations to Etravirine (TMC-125) in Antiretroviral-Naïve Patients Infected with Non-B HIV-1 Subtypes (2009) (46)
- Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. (2005) (46)
- A 6-Month Interruption of Antiretroviral Therapy Improves Adipose Tissue Function in HIV-Infected Patients: The ANRS EP29 Lipostop Study (2007) (46)
- Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years. (2010) (46)
- Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study (2001) (46)
- The unrecognised French BSE epidemic. (2004) (45)
- A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir (2010) (45)
- Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients (2007) (45)
- Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients (2007) (45)
- Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first‐line combination antiretroviral therapy (2015) (45)
- Rates of disease progression according to initial highly active antiretroviral therapy regimen: a collaborative analysis of 12 prospective cohort studies. (2006) (44)
- Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120). (2012) (44)
- Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort. (2015) (44)
- Trends in survival after cancer diagnosis among HIV‐infected individuals between 1992 and 2009. Results from the FHDH‐ANRS CO4 cohort (2015) (44)
- Looking Beyond the Cascade of HIV Care to End the AIDS Epidemic: Estimation of the Time Interval From HIV Infection to Viral Suppression (2016) (44)
- Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements (2009) (44)
- Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine (2011) (43)
- Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study. (2012) (43)
- Response to Highly Active Antiretroviral Therapy at 6 Months and Long-Term Disease Progression in HIV-1 Infection (2005) (43)
- Revealing geographical and population heterogeneity in HIV incidence, undiagnosed HIV prevalence and time to diagnosis to improve prevention and care: estimates for France (2018) (43)
- HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens. (2014) (43)
- Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation. (2009) (42)
- Metabolic syndrome in a French cohort of patients with bipolar disorder: results from the FACE-BD cohort. (2014) (42)
- The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study (2012) (42)
- High Prevalence of Anal Human Papillomavirus-Associated Cancer Precursors in a Contemporary Cohort of Asymptomatic HIV-Infected Women. (2015) (42)
- Response to HAART in French patients with resistant HIV-1 treated at primary infection: ANRS Resistance Network (2007) (42)
- Genotypic Determinants of the Virological Response to Tenofovir Disoproxil Fumarate in Nucleoside Reverse Transcriptase Inhibitor-Experienced Patients (2003) (42)
- Impact of early-untreated HIV infection on chronic hepatitis C in intravenous drug users: a case–control study (2001) (41)
- High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort. (2015) (41)
- Temporal trends in prognostic markers of HIV-1 virulence and transmissibility: an observational cohort study. (2014) (41)
- The Incubation Period of Kuru (2002) (41)
- Higher rates of triple‐class virological failure in perinatally HIV‐infected teenagers compared with heterosexually infected young adults in Europe (2016) (40)
- Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia (2013) (40)
- Time to AIDS from 1992 to 1999 in HIV-1-infected subjects with known date of infection. (2002) (40)
- Low-Rate Emergence of Thymidine Analogue Mutations and Multi-Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Gene in Therapy-Naive Patients Receiving Stavudine plus Lamivudine Combination Therapy (2000) (40)
- Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group. (2016) (39)
- Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study (2019) (39)
- High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors (2011) (38)
- Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response (2006) (38)
- Number of deaths among HIV-infected adults in France in 2000, three-source capture–recapture estimation (2006) (38)
- Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection (2006) (37)
- Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study. (2013) (37)
- Direct HIV testing in blood donations: variation of the yield with detection threshold and pool size (1999) (37)
- Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics. (2012) (37)
- A Meta-Analysis of Six Placebo-Controlled Trials of Thiazolidinedione Therapy for HIV Lipoatrophy (2010) (37)
- Limited Impact of Immunosuppression and Haart on the Incidence of Cervical Squamous Intraepithelial Lesions in HIV-Positive Women (2006) (36)
- Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy–Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals (2018) (36)
- Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy–Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals (2018) (36)
- Prevalence of markers for human immunodeficiency virus types 1 and 2, human T‐lymphotropic virus type I, cytomegalovirus, and hepatitis B and C virus in multiply transfused thalassemia patients. The French Study Group On Thalassaemia (1992) (35)
- Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy. (2016) (35)
- Cohort Profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. (2016) (35)
- Heterosexual risk of HIV transmission per sexual act under combined antiretroviral therapy: systematic review and bayesian modeling. (2014) (34)
- Significant reduction in HIV virologic failure during a 15-year period in a setting with free healthcare access. (2015) (34)
- Reproducibility of non-invasive measurement and of short-term variability of blood pressure and heart rate in healthy volunteers. (1994) (33)
- NYVAC immunization induces polyfunctional HIV‐specific T‐cell responses in chronically‐infected, ART‐treated HIV patients (2012) (33)
- Twelve Months of Routine HIV Screening in 6 Emergency Departments in the Paris Area: Results from the ANRS URDEP Study (2012) (33)
- Alpha interferon administration during structured interruptions of combination antiretroviral therapy in patients with chronic HIV-1 infection: INTERVAC ANRS 105 trial (2011) (33)
- Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study (2017) (33)
- HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART (2007) (33)
- HIV-associated tuberculosis and immigration in a high-income country: incidence trends and risk factors in recent years (2010) (32)
- IL-2 therapy and thymic production of naive CD4 T cells in HIV-infected patients with severe CD4 lymphopenia (2003) (32)
- Alterations of self-reactive antibody repertoires in HIV disease: an insight into the role of T cells in the selection of autoreactive B cells. (2005) (32)
- Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia (2016) (32)
- Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients. (2010) (32)
- Burden of HIV and hepatitis C co‐infection: the changing epidemiology of hepatitis C in HIV‐infected patients in France (2015) (31)
- Single-nucleotide polymorphism-defined class I and class III major histocompatibility complex genetic subregions contribute to natural long-term nonprogression in HIV infection. (2012) (31)
- Effect of Baseline CD4 Cell Counts on the Clinical Significance of Short-Term Immunologic Response to Antiretroviral Therapy in Individuals With Virologic Suppression (2009) (31)
- Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention (2011) (31)
- Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/μl (2009) (31)
- Contraceptive Use in HIV-Positive Women (2004) (31)
- Blunted Response to Combination Antiretroviral Therapy in HIV Elite Controllers: An International HIV Controller Collaboration (2014) (31)
- Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trial. (2015) (31)
- Timing of human immunodeficiency virus type 1 (HIV-1) transmission from mother to child: bayesian estimation using a mixture. (1999) (30)
- Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study. (2014) (30)
- Causes of death in HIV-infected women: persistent role of AIDS. The 'Mortalité 2000 & 2005' Surveys (ANRS EN19). (2010) (29)
- Vitamin D supplementation is associated with reduced immune activation levels in HIV-1-infected patients on suppressive antiretroviral therapy (2014) (29)
- Imported Malaria in HIV-Infected Patients Enrolled in the ANRS CO4 FHDH Study (2008) (29)
- HIV‐associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV (2007) (29)
- Can antiviral agents decrease the occurrence of Kaposi's sarcoma? (1995) (29)
- Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patients (2004) (28)
- Wild type and H43Y variant of human TRIM5α show similar anti-human immunodeficiency virus type 1 activity both in vivo and in vitro (2007) (28)
- Breast cancer among HIV infected individuals from the ONCOVIH study, in France: therapeutic implications. (2012) (28)
- The prevalence of diabetes mellitus in the adult population of Guadeloupe as estimated by history or fasting hyperglycemia. (1991) (28)
- CD4+ T-cell percentage is an independent predictor of clinical progression in AIDS-free antiretroviral-naive patients with CD4+ T-cell counts >200 cells/mm3 (2008) (28)
- CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era (2018) (28)
- Maintaining antiretroviral therapy reduces the risk of AIDS-defining events in patients with uncontrolled viral replication and profound immunodeficiency. (2008) (27)
- Boosted protease inhibitor monotherapy as a maintenance strategy: an observational study (2012) (27)
- Prevalence of low bone mineral density in men and women infected with human immunodeficiency virus 1 and a proposal for screening strategy. (2012) (27)
- Virological and pharmacological factors associated with virological response to salvage therapy after an 8‐week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097) (2005) (27)
- Paper #1030The Spectrum of Engagement in HIV Care in France: Strengths and Gaps (2013) (27)
- Prevalence of and Risk Factors for Anal Oncogenic Human Papillomavirus Infection Among HIV-Infected Women in France in the Combination Antiretroviral Therapy Era. (2016) (26)
- How does loss to follow‐up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalité 2000 survey and death certificates * (2009) (26)
- Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group. (1999) (26)
- Bleeding complications in primary percutaneous coronary intervention of ST‐elevation myocardial infarction in a radial center (2012) (26)
- Statin therapy and low‐density lipoprotein cholesterol reduction in HIV‐infected individuals after acute coronary syndrome: Results from the PACS‐HIV lipids substudy (2017) (26)
- Survival after neuroAIDS (2011) (26)
- Enoxaparin anticoagulation monitoring in the catheterization laboratory using a new bedside test. (2010) (26)
- Including polymerase chain reaction in screening for hepatitis C virus RNA in blood donations is not cost‐effective (2001) (26)
- The cost of diabetes in France. (1988) (26)
- Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis. (2013) (26)
- Apparent enhancement of perinatal transmission of human immunodeficiency virus type 1 by high maternal anti-gp160 antibody titer. (1998) (26)
- Initiation of Insulin Treatment after 70 Years of Age: Patient Status 2 Years Later (1991) (25)
- Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy (2013) (25)
- Differences in androgens of HIV positive patients with and without Kaposi sarcoma. (1995) (25)
- Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor‐sparing therapy in patients with lipoatrophy: results from the 96‐week randomized ANRS 108 NoNuke Trial (2008) (24)
- Bivariate Longitudinal Model For The Analysis Of The Evolution Of Hiv Rna And Cd4 Cell Count In Hiv Infection Taking Into Account Left Censoring Of Hiv Rna Measures (2003) (24)
- Lack of regression of anal squamous intraepithelial lesions despite immune restoration under cART (2013) (24)
- Impact of Insertions in the HIV-1 P6 Ptapp Region on the Virological Response to Amprenavir (2004) (24)
- Incubation time for AIDS from French transfusion-associated cases (1989) (24)
- Efficacy and Safety of Ritonavir/Indinavir 100/400 Mg Twice Daily in Combination with Two Nucleoside Analogues in Antiretroviral Treatment-Naive HIV-Infected Individuals (2002) (24)
- Relations between Doppler tracings of pulmonary regurgitation and invasive hemodynamics in acute right ventricular infarction complicating inferior wall left ventricular infarction. (1995) (23)
- Outcomes for bipolar patients assessed in the French expert center network: A 2‐year follow‐up observational study (FondaMental Advanced Centers of Expertise for Bipolar Disorder [FACE‐BD]) (2017) (23)
- Transfusion-associated AIDS cases in Europe: estimation of the incubation period distribution and prediction of future cases. (1991) (23)
- Relevance of EORTC Criteria for the Diagnosis of Invasive Aspergillosis in HIV-Infected Patients, and Survival Trends Over a 20-Year Period in France. (2015) (23)
- Surgical management of cervical intraepithelial neoplasia in HIV-infected women. (2008) (23)
- Tolerability of anti-tuberculosis treatment and HIV serostatus. (2007) (23)
- Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study. (2019) (22)
- Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial. (2016) (22)
- Clinical and immunologic outcome in patients with human immunodeficiency virus infection, according to virologic efficacy in the year after virus undetectability, during antiretroviral therapy. (2003) (22)
- Modeling the Time Course of CD4 T-Lymphocyte Counts According to the Level of Virologic Rebound in HIV-1–Infected Patients on Highly Active Antiretroviral Therapy (2003) (22)
- Characteristics of the env Genes of HIV Type 1 Quasispecies in Long-Term Nonprogressors With Broadly Neutralizing Antibodies (2008) (21)
- Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved? (2015) (21)
- Distinct differentiation profiles of HIV-Gag and Nef-specific central memory CD8+ T cells associated with HLA-B57/5801 and virus control (2010) (21)
- Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia: The FACE-SZ Cohort. (2018) (21)
- Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial (2018) (21)
- Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course (2017) (21)
- Increased cardiovascular risk in HIV infection: drugs, virus and immunity. (2008) (20)
- Are European HIV cohort data within EuroCoord representative of the diagnosed HIV population? (2018) (20)
- Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice? (2008) (20)
- A new approach to estimating AIDS incubation times: results in homosexual infected men. (1992) (20)
- Is Impact of Statin Therapy on All-Cause Mortality Different in HIV-Infected Individuals Compared to General Population? Results from the FHDH-ANRS CO4 Cohort (2015) (19)
- Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir. (2008) (19)
- Arterial hypertension in the adult population of Guadeloupe, and associated factors in subjects of African origin. (1996) (19)
- Correction: How much would the safety of blood transfusion be improved by including p24 antigen in the battery of tests? (1995) (19)
- Altered Heterochromatin Organization after Perinatal Exposure to Zidovudine (2007) (19)
- Towards a new predictor of AIDS progression through the quantisation of HIV‐1 DNA copies by PCR in HIV‐infected individuals (1992) (19)
- T-cell activation positively correlates with cell-associated HIV-DNA level in viremic patients with primary or chronic HIV-1 infection (2014) (19)
- Calendar Time Trends in the Incidence and Prevalence of Triple-Class Virologic Failure in Antiretroviral Drug-Experienced People With HIV in Europe (2011) (18)
- Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial. (2008) (18)
- Comparison of the Dynamics of Resistance-Associated Mutations to Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside Reverse Transcriptase Inhibitors, and Protease Inhibitors after Cessation of Antiretroviral Combination Therapy (2004) (18)
- Adverse outcome analyses of observational data: assessing cardiovascular risk in HIV disease. (2012) (18)
- Influence of Mother and Infant Zidovudine Treatment Duration on the Age at Which HIV Infection Can be Detected by Polymerase Chain Reaction in Infants (2004) (18)
- Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials. (2016) (17)
- Long-term Nonprogression in Hiv Infection (1997) (17)
- Serious psychiatric outcome of subjects prenatally exposed to diethylstilboestrol in the E3N cohort study (2007) (17)
- Causes et caractéristiques des décès des patients infectés par le VIH-1, en succès immuno-virologique sous traitement antirétroviral (2004) (17)
- Markov modelling of changes in HIV‐specific cytotoxic T‐lymphocyte responses with time in untreated HIV‐1 infected patients (2003) (17)
- Targeted HIV Screening in Eight Emergency Departments: The DICI‐VIH Cluster‐Randomized Two‐Period Crossover Trial (2017) (17)
- High indinavir plasma concentrations in HIV-positive patients co-infected with hepatitis B or C virus treated with low doses of indinavir and ritonavir (400/100 mg twice a day) plus two nucleoside reverse transcriptase inhibitors. (2003) (17)
- Evaluating therapeutic vaccines in patients infected with HIV (2004) (17)
- Sleep quality, chronotype and metabolic syndrome components in bipolar disorders during the remission period: Results from the FACE-BD cohort (2017) (17)
- HEPATITIS B VACCINE AND THE RISK OF CNS INFLAMMATORY DEMYELINATION IN CHILDHOOD (2009) (17)
- First-line Highly Active Antiretroviral Regimens in 2001–2002 in the French Hospital Database on HIV: Combination Prescribed and Biological Outcomes (2006) (17)
- Better health-related quality of life after switching from a virologically effective regimen to a regimen containing efavirenz or nevirapine (2010) (16)
- Trends in Post-Infection CD4 Cell Counts and Plasma HIV-1 RNA Levels in HIV-1–Infected Patients in France Between 1997 and 2005 (2009) (16)
- Pneumocystis carinii Pneumonia Recurrence in HIV Patients on Highly Active Antiretroviral Therapy: Secondary Prophylaxis (2001) (16)
- Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma‐derived FVIII or FIX concentrate: results from the French haemophilia cohort (2002) (16)
- CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppression (2014) (16)
- Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1–Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy (2018) (16)
- Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study. (2019) (16)
- Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older (2017) (16)
- Recurrence and Occurrence of Kaposi's Sarcoma in Patients Living With Human Immunodeficiency Virus (HIV) and on Antiretroviral Therapy, Despite Suppressed HIV Viremia. (2020) (15)
- Obesity in HIV-infected patients in France: prevalence and surgical treatment options. (2015) (15)
- Propensity score analysis of artesunate versus quinine for severe imported Plasmodium falciparum malaria in France. (2019) (15)
- Clinical Progression Rates by CD4 Cell Category Before and After the Initiation of Combination Antiretroviral Therapy (cART) (2008) (15)
- Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death. (2020) (15)
- When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study (2016) (15)
- RE: EARLY OUTPATIENT TREATMENT OF SYMPTOMATIC, HIGH-RISK COVID-19 PATIENTS THAT SHOULD BE RAMPED-UP IMMEDIATELY AS KEY TO THE PANDEMIC CRISIS (2020) (15)
- HIV-1-RNA in seminal plasma correlates with detection of HIV-1-DNA in semen cells, but not with CMV shedding, among MSM on successful antiretroviral regimens. (2016) (14)
- When is the epidemic warning cut-off point exceeded? (1994) (14)
- Yearly number of patients diagnosed with primary HIV-1 infection in France estimated by a capture–recapture approach (2006) (14)
- How much would the safety of blood transfusion be improved by including p24 antigen in the battery of tests? (1995) (14)
- Place relative des essais cliniques comparatifs et des suivis de cohorte dans l’évaluation préet post-AMM des médicaments (2005) (14)
- Anti‐HBc Testing Can Decrease the Residual Risk of Transfusion‐Related HIV Transmission by More Than One Third (1990) (14)
- Cell cycle models and mother-daughter correlation. (1988) (14)
- Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4) (2018) (14)
- Access to the waiting list and to kidney transplantation for people living with HIV: A national registry study (2019) (14)
- CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study (2017) (14)
- Quantitation of cytomegalovirus (CMV) DNA by real‐time PCR for occurrence of CMV disease in HIV‐infected patients receiving highly active antiretroviral therapy (2003) (14)
- Including pre-AIDS mortality in back-calculation model to estimate HIV prevalence in France, 2000 (2006) (13)
- MHC-driven HIV-1 control on the long run is not systematically determined at early times post-HIV-1 infection (2013) (13)
- Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4 (2017) (13)
- Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study. (2017) (13)
- Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohort. (2017) (13)
- Initiatives for developing and comparing genotype interpretation systems: external validation of existing systems for didanosine against virological response. (2008) (13)
- The French haemophilia cohort: rationale and organization of a long‐term national pharmacosurveillance system (2001) (13)
- Management of type 2 diabetes mellitus in France: attitudes and practices among a representative sample of general practitioners. (1994) (12)
- Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy (2016) (12)
- Impact of Newly Available Drugs on Clinical Progression in Patients with Virological Failure after Exposure to Three Classes of Antiretrovirals (2005) (12)
- Irbesartan combined with conventional therapy, including angiotensin converting enzyme inhibitors, in heart failure (1998) (12)
- Usefulness of pulmonary regurgitation Doppler tracings in predicting in-hospital and long-term outcome in patients with inferior wall acute myocardial infarction. (1998) (12)
- Later cART Initiation in Migrant Men from Sub-Saharan Africa without Advanced HIV Disease in France (2015) (12)
- How PrEP users constitute a community in the MSM population through their specific experience and management of stigmatization. The example of the French ANRS-PREVENIR study (2020) (12)
- Prognosis of HIV-1 infected drug naïve patients starting potent antiretroviral therapy. ART Cohort Collaboration (2002) (12)
- Interleukin 2 treatment does not modify hepatitis B or C replication in human immunodeficiency virus–infected patients: Results from a randomized control trial (2002) (12)
- Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study. (2022) (12)
- Switch from a first virologically effective protease inhibitor-containing regimen to a regimen containing efavirenz, nevirapine or abacavir (2006) (12)
- Estimating incidence of the French BSE infection using a joint analysis of both asymptomatic and clinical BSE surveillance data. (2007) (12)
- Traitement médicamenteux de l’ostéoporose post-ménopausique: Actualisation 2006 (2006) (12)
- The risk of diabetic control: A comparison of hospital versus general practice supervision (1982) (12)
- Prevalence of complete resistance to at least two classes of antiretroviral drugs in treated HIV‐1‐infected patients: A French nationwide study (2005) (11)
- A Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Sequences in Kiev: Findings Among Key Populations (2017) (11)
- Factors predictive of disease progression and death in AIDS‐related Kaposi's sarcoma (2000) (11)
- Is the AIDS incubation time changing? A back-calculation approach. (1999) (11)
- Complementary Approach of Data Analysis and Modeling to Estimate the Pattern of the BSE Epidemic: The Example of France (2007) (11)
- Randomized study of two doses of didanosine in children infected with human immunodeficiency virus. (1993) (11)
- New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon (2015) (11)
- Characteristics of B-Cell Lymphomas in HIV/HCV-Coinfected Patients During the Combined Antiretroviral Therapy Era: An ANRS CO16 LYMPHOVIR Cohort Study (2013) (11)
- Performance of the marginal structural cox model for estimating individual and joined effects of treatments given in combination (2017) (11)
- How was the French BSE epidemic underestimated? (2006) (11)
- Incidence of AIDS in HIV‐1 infected thalassaemia patients (1992) (11)
- Trends in the risk of myocardial infarction among HIV-1-infected individuals relative to the general population in France: Impact of gender and immune status (2019) (11)
- Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen (2018) (11)
- Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV‐positive individuals (2019) (11)
- Hemodynamic criteria for diagnosis of right ventricular ischemia associated with inferior wall left ventricular acute myocardial infarction. (1995) (11)
- Prevalence of non-insulin dependent diabetes as perceived by general practitioners in France. (1995) (11)
- Validation and refinement of the clinical staging model in a French cohort of outpatient with schizophrenia (FACE-SZ) (2019) (11)
- The Cost of Managing HIV Infection in Highly Treatment-Experienced, HIV-Infected Adults in France (2012) (11)
- Time for a revolution in tracking the HIV epidemic. (2016) (10)
- Interleukine-2 Therapy Does Not Increase the Risk of Hodgkin or Non-Hodgkin Lymphoma in HIV-Infected Patients: Results From FHDH ANRS CO4 (2009) (10)
- Predicting progression of HIV disease: usefulness of acid-dissociated p24 antigen. (1994) (10)
- National survey of the prevalence and conditions of selection of HIV‐1 reverse transcriptase K70E mutation (2008) (10)
- Visit-driven endpoints in randomized HIV/AIDS clinical trials: impact of missing data on treatment difference measured on summary statistics. (1999) (10)
- Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ : CD8+ ratio (2018) (10)
- A new SARS-CoV-2 variant poorly detected by RT-PCR on nasopharyngeal samples, with high lethality: an observational study (2021) (10)
- Didanosine Dosed Once Daily Is Equivalent to Twice Daily Dosing for Patients on Double or Triple Combination Antiretroviral Therapy (2000) (10)
- The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment (2016) (10)
- Estimates of the HIV undiagnosed population in Belgium reveals higher prevalence for MSM with foreign nationality and for geographic areas hosting big cities (2019) (10)
- HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort) (2019) (9)
- The French haemophilia cohort: rationale and organization of a long-term national pharmacosurveillance system. (2001) (9)
- Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence? (2019) (9)
- Low incidence of acute rejection within 6 months of kidney transplantation in HIV‐infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) 153 TREVE trial (2019) (9)
- Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group (2021) (9)
- Les nouvelles tumeurs malignes du patient infecté par le VIH : aspects cliniques et perspectives (2006) (9)
- L'introduction de la PCR dans le dépistage du virus de l'hépatite C dans les dons de sang : du mésusage du principe de précaution (2001) (9)
- Fat gain differs by sex and hormonal status in persons living with suppressed HIV switched to raltegravir/etravirine. (2020) (9)
- Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibitor + nucleoside reverse transcriptase inhibitor in (2009) (9)
- IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy--results from the ANRS CO4 cohort. (2010) (8)
- Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression (2017) (8)
- Cause‐specific mortality after diagnosis of cancer among HIV‐positive patients: A collaborative analysis of cohort studies (2020) (8)
- Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress? (2020) (8)
- Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial). (2016) (8)
- Lack of association between human leukocyte antigens and the anti-Hu syndrome in patients with small-cell lung cancer. (1998) (8)
- [Causes and characteristics of death among HIV-1 infected patients with immunovirologic response to antiretroviral treatment]. (2004) (8)
- Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? (2018) (8)
- A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial. (2022) (8)
- Determinants of Low-Density Lipoprotein Particle Diameter during Antiretroviral Therapy Including Protease Inhibitors in HIV-1-Infected Patients (2012) (8)
- CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies. (2021) (8)
- Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial). (2015) (8)
- HIV Infection and Long‐Term Residual Cardiovascular Risk After Acute Coronary Syndrome (2020) (8)
- [Educational diagnosis and evaluation of educational strategies (PRECEDE Model): practical methodology for inducing changes in behavior and health status]. (1991) (8)
- Risk factors for loss to follow‐up, transfer or death among people living with HIV on their first antiretroviral therapy regimen in Mali (2018) (8)
- Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir. (2011) (8)
- Effects of rosuvastatin versus pravastatin on low-density lipoprotein diameter in HIV-1-infected patients receiving ritonavir-boosted protease inhibitor (2012) (8)
- Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE) (2022) (8)
- CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus (2017) (8)
- Children and young people with perinatal HIV in Europe: epidemiological situation in 2014 and implications for the future (2016) (7)
- Cumulative incidence of HIV infection and AIDS case prediction in France (1993) (7)
- Increase of HIV-1 Pro-Viral Dna per Million Peripheral Blood Mononuclear Cells in Patients with Advanced HIV Disease (Cd4<200 Cells/Mm3) Receiving Interleukin 2 Combined with Haart Versus Haart Alone (Anrs-082 Trial) (2002) (7)
- [Non-AIDS-defining malignancies in HIV patients: clinical features and perspectives]. (2006) (7)
- Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France (2016) (7)
- Impact of Antiretroviral Drugs on Fracture Risk in HIV-Infected Individuals: A Case–Control Study Nested Within the French Hospital Database on HIV (FHDH-ANRS CO4) (2019) (7)
- Pneumocystis and pneumocystosis in Europe at the end of the 20th century. (1998) (7)
- Undiagnosed HIV prevalence in France: no evidence against universal HIV screening. (2012) (7)
- Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes. (2013) (7)
- BSE Risk Assessment as a Basis for Updating French Screening Policy (2007) (7)
- Cancers in elite controllers: appropriate follow-up is essential (2016) (7)
- Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH). (2020) (7)
- Incubation time for AIDS (1987) (7)
- Early initiation of treatment for HIV infection (2010) (7)
- Switch to maraviroc/raltegravir dual therapy leads to an unfavorable immune profile with low-level HIV viremia (2015) (7)
- Lopinavir/r no longer recommended as a first-line regimen: a comparative effectiveness analysis (2014) (7)
- Risk-benefit analysis of nucleic acid testing: the French experience. (1999) (7)
- Modifications of hemato-biological parameters in pregnant women in a migrating population in northern Cameroon: prevalence of anemia, iron and folates deficiencies. (1987) (7)
- Association of CD4:CD8 With Cause-Specific Mortality in Patients on Long-Term ART (2015) (6)
- Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries. (2015) (6)
- Switching to Raltegravir From a Virologically Effective Boosted Protease Inhibitor Regimen: A Comparative Effectiveness Analysis From the French Hospital Database on HIV (FHDH-ANRS CO4). (2016) (6)
- Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV. (2019) (6)
- Trajectories of functioning in bipolar disorders: A longitudinal study in the FondaMental Advanced Centers of Expertise in Bipolar Disorders cohort (2020) (6)
- Differences in the frequency of minor substitutions between HIV-1 subtypes and their potential impact on the genetic barrier for resistance to protease inhibitors (2005) (6)
- Nevirapine‐associated toxicity in Niger (2008) (6)
- Telephone versus face to face interviewing as a means of collecting data relevant to the management of diabetes among general practitioners in France: a randomized design. (1989) (6)
- Critical Importance of Long-Term Adherence to Care in HIV Infected Patients in the cART Era: New Insights from Pneumocystis jirovecii Pneumonia Cases over 2004–2011 in the FHDH-ANRS CO4 Cohort (2014) (6)
- Estimation of the size of the HIV/AIDS epidemic due to blood transfusion in France. (1995) (6)
- In situ BCL2 expression is an independent prognostic factor in HIV‐associated DLBCL, a LYMPHOVIR cohort study (2020) (6)
- Modelling the Budget Impact of Darunavir in the Treatment of Highly Treatment-Experienced, HIV-Infected Adults in France (2012) (6)
- Nucleoside analogue use before and during highly active antiretroviral therapy and virus load rebound. (2004) (6)
- Use of darunavir in HIV-1-infected individuals in routine clinical practice from 2012 to 2016 in France. (2019) (6)
- Epstein-Barr virus transactivator antibodies in HIV infection (1991) (6)
- Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4: CD8 ratio: ART Cohort Collaboration (ART-CC) Study. (2018) (6)
- Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection (2020) (6)
- Prevalence of tubulopathy and association with renal function loss in HIV-infected patients. (2020) (6)
- On the comparison of artificial network and interpretation systems based on genotype resistance mutations in HIV-1-infected patients (2006) (6)
- A step ahead on the HIV collaboratory. (2009) (6)
- Epidemiologic comparison of human T‐lymphotropic virus type I‐infected blood donors from endemic and nonendemic regions over a 3‐year period (1994) (6)
- Didanosine dosed once daily is equivalent to twice daily dosing for patients on double or triple combination antiretroviral therapy. The AI454-147 Team. (2000) (6)
- Potential lung cancer screening outcomes using different age and smoking thresholds in the ANRS‐CO4 French Hospital Database on HIV cohort (2019) (6)
- Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19 (2022) (6)
- Interobserver variability of cervical cytology in HIV‐infected women (2015) (5)
- Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice. (2012) (5)
- No influence of human herpesvirus 8 infection on the progression of HIV‐1 infection in initially asymptomatic patients (2003) (5)
- Causes de décès des personnes infectées par le VIH en 2000 : persistance du sida, rôle émergent des cancers et des hépatites. (2004) (5)
- Some keys factors in the clinical diagnosis of non insulin-dependent diabetes: a multinational comparison. (1989) (5)
- Épidémiologie de l'infection à VIH en France et en Europe (2008) (5)
- Lack of effects of statins on high-density lipoprotein subfractions in HIV-1-infected patients receiving protease inhibitors. (2017) (5)
- Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer (2022) (5)
- Development of a didanosine genotypic resistance interpretation system based on large derivation and validation datasets (2010) (5)
- The HIV continuum of care in European Union countries in 2013: data and challenges (2017) (5)
- Which adults in the Paris metropolitan area have never been tested for HIV? A 2010 multilevel, cross-sectional, population-based study (2015) (5)
- Épidémiologie du cancer de l’anus (2011) (5)
- Utility of Epstein-Barr Virus Biomarkers in Human Immunodeficiency Virus-related Lymphomas in the Modern Combined Antiretroviral Therapy Era. (2018) (5)
- 10th Conference on Retroviruses and Opportunistic Infections 2003 Boston, USA (2003) (5)
- Immunocompromised patients have been neglected in COVID-19 trials: a call for action (2022) (5)
- Zidovudine in Patients with HIV Infection (1996) (5)
- Relative contributions of baseline patient characteristics and the choice of statistical methods to the variability of genotypic resistance scores: the example of didanosine. (2010) (5)
- GBD 2013 and HIV incidence in high income countries (2015) (5)
- Estimate of HIV incidence in childbearing women in the Paris area, France. (1997) (5)
- Favorable outcome of HIV-associated Burkitt lymphoma in the modern combined antiretroviral therapy era. (2020) (5)
- Does enfuvirtide increase the risk of bacterial pneumonia in patients receiving combination antiretroviral therapy? (2010) (4)
- Initiatives for developing and comparing genotype interpretation systems Step 1: External validation of existing rules-based algorithm for abacavir and ddi evaluated on virological response (2005) (4)
- Epidemiology of Kaposi’s Sarcoma (2021) (4)
- Comparison of different data collection methods within a study sample: telephone versus home interviews (1989) (4)
- Blood donation and HIV infection: impact of seroconversion delay on the sensitivity of the testing procedure. (1989) (4)
- Comparative biological and clinical outcomes after a switch from a virologically unsuccessful first protease inhibitor-containing antiretroviral combination to a 3-drug regimen containing efavirenz, nevirapine, or abacavir. (2007) (4)
- HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtide. (2008) (4)
- Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma (2019) (4)
- [The epidemiology of cerebral lymphoma in AIDS]. (1995) (4)
- Lack of a Clinically Significant Pharmacokinetic Interaction between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS‐163 ETRAL Study (2019) (4)
- Dual Nucleoside Reverse Transcriptase Inhibitor Therapy in the Combination Antiretroviral Therapy Era and Predictors of Discontinuation or Switch to Combination Antiretroviral Therapy (2008) (4)
- Muscle and Liver Lactate Metabolism in Haart-Treated and Naive HIV-Infected Patients: The Mitovir Study (2005) (4)
- L'annonce du diagnostic d'infection à VIH : un verdict traumatique (1998) (4)
- Revealing HIV epidemic dynamics and contrasting responses in two WHO Eastern European countries: insights from modeling and data triangulation. (2020) (4)
- Susceptibility to Creutzfeldt-Jakob disease after human growth hormone treatment in France (2018) (4)
- Cellular proliferation in the spleen of DBA/2 mice infected with a myeloproliferative sarcoma virus(MPSV). (1981) (4)
- Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern cART era. (2019) (4)
- Do people living with HIV face more secondary cancers than general population: From the French CANCERVIH network. (2021) (4)
- [Epidemiology of HIV infection in France and Europe]. (2008) (4)
- Metabolic Syndrome and Cardiovascular Disease Impacts on the Pathophysiology and Phenotype of HIV-Associated Neurocognitive Disorders. (2020) (4)
- Characterization of Epstein–Barr Virus LMP1 deletion variants by Next-Generation Sequencing in HIV-associated Hodgkin Lymphoma (French ANRS CO16 LYMPHOVIR cohort) (2016) (4)
- Lamivudine and Indinavir/Ritonavir Maintenance Therapy in Highly Pretreated HIV-Infected Patients (Vista Anrs 109) (2005) (4)
- A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study (2021) (4)
- Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial (2022) (4)
- Key findings on bipolar disorders from the longitudinal FondaMental Advanced Center of Expertise-Bipolar Disorder (FACE-BD) cohort. (2022) (4)
- Long-term nonprogression in HIV infection. Clinical Epidemiology Group from the Centre d'Information et de Soins de l'Immunodéficience Humaine. (1997) (4)
- [Retirement, psychological well-being and health: longitudinal study of a population of Parisian executives]. (1983) (3)
- Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era. (2019) (3)
- Effect of interferon alpha on high serum androgen concentrations in HIV positive men with Kaposi's sarcoma. (1997) (3)
- BEDSIDE ESTIMATION OF MICROALBUMINURIA (1986) (3)
- Prospective evaluation of blood Epstein–Barr virus DNA load and antibody profile in HIV-related non-Hodgkin lymphomas (2021) (3)
- Screening HIV patients at risk for NAFLD using MRI-PDFF and transient elastography: a European multicenter prospective study. (2022) (3)
- A rational attitude toward serum alanine aminotransferase measurement by blood banks, based on a longitudinal study of a cohort of repeat blood donors (1991) (3)
- Hepatitis C virus (HCV) incidence among men who have sex with men (MSM) living with HIV: results from the French Hospital Database on HIV (ANRS CO4-FHDH) cohort study, 2014 to 2017 (2021) (3)
- Survival in individuals living with HIV (2016) (3)
- SMBG in NIDDM Patients Treated by General Practitioners in France (1990) (3)
- Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice (2015) (3)
- HCV or HBV coinfection and lymphoma risk in people living with HIV. (2019) (3)
- The impact of nurse-driven targeted HIV screening in 8 emergency departments: study protocol for the DICI-VIH cluster-randomized two-period crossover trial (2015) (3)
- Trends in zidovudine prescription since 1987 in AIDS-free HIV-positive French patients attending university hospitals. (1992) (3)
- Risk Factors for Seborrhoeic Dermatitis Flares: Case-control and Case-crossover Study (2020) (3)
- Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes (2016) (3)
- Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological Conditions (2017) (3)
- [Prevalence of HIV infection in France before the introduction of early treatment: estimation by back-calculation]. (1993) (3)
- Decreased peripheral circulation of HIV-infected cells in a subset of long-term nonprogressors. The French ALT Study Group. (1999) (3)
- β-Blocker use for patients with or at risk for coronary artery disease. (2013) (3)
- [HIV-1 quantitative dynamics in vivo: a review of mathematical models]. (2000) (3)
- One or two enzyme-linked immunosorbent assay tests on the first serum sample for initial diagnosis of HIV-1 infection? (2008) (3)
- Influence of control selection in nested case‐control studies: the example of exposure to antiretroviral treatment (ART) and the risk of myocardial infarction (MI) in the French Hospital Database on HIV (FHDH‐ANRS CO4) (2008) (2)
- Pharmacological data of a successful 4‐days‐a‐week regimen in HIV antiretroviral therapy (ANRS 162‐4D trial) (2020) (2)
- Distribution, characteristics, and prognostic of AIDS and non-AIDS cancers in HIV-infected patients, the ONCOVIH study (2009) (2)
- Observation versus intervention in the evaluation of drugs: the story of hormone replacement therapy. (2007) (2)
- [Analysis of delay in reporting of acquired immunodeficiency syndrome in France]. (1993) (2)
- Construction and validation of a prognostic model for progression to AIDS or death in drug-naïve patients starting potent antiretroviral therapy. ART Cohort Collaboration (2002) (2)
- Comparative eff ectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study (2015) (2)
- HIV Incidence Estimates Among Women of Childbearing Age in the Area Around Paris, France: No Evidence for Any Effect of Age or Time (2001) (2)
- 012 Acute coronary syndrome in HIV-infected patients: characteristics and prognosis (2011) (2)
- International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK (2016) (2)
- Impact of smoking on life expectancy among HIV-infected individuals: The ART Cohort Collaboration (2014) (2)
- Household transmission of SARS-CoV-2 infection in the Paris/Ile-de-France area (2022) (2)
- Risk of HIV transmission under combined antiretroviral therapy: toward risk zero? (2015) (2)
- Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care? (2020) (2)
- [HIV and cancer : What's new in 2017?] (2018) (2)
- The French Hospital Database on HIV (FHDH) ANRS CO 4 (2008) (2)
- Editorial commentary: Myocardial infarction in HIV-infected persons: time to focus on the silent elephant in the room? (2015) (2)
- Effect of interferon on high serum androgen concentrations in HIV positive men with Kaposi's sarcoma (2)
- Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen (2018) (2)
- Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens (2010) (2)
- Impact of opportunistic diseases on survival in HIV-infected patients in France, 1992-1997. Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodéficience Humaine. (1999) (2)
- Remdesivir for the Treatment of Hospitalised Patients with COVID-19 (DisCoVeRy): A Randomised, Controlled, Open-Label Trial (2021) (2)
- Impact of etravirine on hospitalization rate between 2005 and 2011 among heavily treated HIV-1-infected individuals on failing regimens (2018) (2)
- Impact of migration origin on individual protection strategies against sexual transmission of HIV in Paris metropolitan area, SIRS cohort study, France (2015) (2)
- Performance of Quantiferon(®) for the diagnosis TB. (2012) (2)
- Lifelong variations in heart rates in SPF Sprague Dawley rats of both sexes (1979) (2)
- Estimation of the number of HIV-seropositive patients known to general practitioners in France. (1994) (2)
- 26 LIVER RELATED DEATHS IN HIV-INFECTED PATIENTS BETWEEN 2000 AND 2010. RESULTS OF THE FRENCH NATIONAL SURVEY “ANRS EN20 MORTALITE 2010” (2012) (2)
- COVID-19: individual and herd immunity. (2021) (2)
- Risk of cancers in HIV infection. (2013) (2)
- Persistence of anal squamous intraepithelial lesions and anal HPV infection in HIV-infected patientsdespite immune restoration under cART (2010) (2)
- Projection of age of individuals living with HIV and time since ART initiation in 2030: estimates for France (2022) (2)
- Risk of AIDS‐defining cancers in HIV‐1‐infected patients (1992–2009): results from FHDH‐ANRS CO4 (2012) (2)
- Rapid plasma viral suppression in naive HIV-infected patients with high CD4 cells and low viraemia initiating a dual nucleoside reverse transcriptase inhibitor strategy: a proof-of-concept study. (2014) (2)
- Routine screening for HIV, hepatitis B virus and hepatitis C virus in individuals undergoing oral and maxillofacial surgery (2019) (2)
- Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial (2023) (2)
- Characteristics of B-cell lymphomas in HIV/HCV-coinfected patients. (2014) (2)
- Le cancer du col de l'utérus : nouvelles stratégies de dépistage ? (2008) (2)
- Causes de décès des patients infectés par le VIH en France: enquête ≪ mortalité 2000 ≫ réalisée avec le soutien de la SNFMI, APPIT, FNCLS, SPILF et de l'ANRS (2001) (2)
- Les freins au dépistage du VIH dans l’agglomération parisienne en 2010 : une analyse transversale multiniveaux de la cohorte SIRS (2014) (2)
- du poumon par le scanner hélicoïdal est-il justifié ? (2007) (2)
- Prix Nobel de Médecine 2008 (Françoise Barré-Sinoussi et Luc Montagnier) : Une vie consacrée à combattre le Sida (2008) (2)
- Causes et caractéristiques des décès en France des adultes infectés par le VIH: Enquête Mortalité 2005, ANRS-EN19 en collaboration avec Mortavic (2006) (2)
- [Evaluation of compliance with antiretroviral treatment in a cohort of 200 patients in Djibouti, 2005]. (2007) (2)
- Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study (2022) (1)
- Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials (2023) (1)
- Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-authors' response. (2020) (1)
- Increasing prevalence of HIV-1 non-B subtypes across Europe from 1996-1999 to 2000-2002; results from the CATCH-study (2004) (1)
- Quantitative markers for cytomegalovirus disease in HIV-infected patients receiving highly active antiretroviral therapy. (2003) (1)
- Lack of association between human leukocyte antigens and the anti‐Hu syndrome in patients with small‐cell lung cancer (1998) (1)
- Can HIV epidemics among MSM be eliminated through participation in preexposure prophylaxis rollouts? (2021) (1)
- Characteristics and Outcome of HIV Associated Classical Hodgkin's Lymphoma Among 68 Patients Included in the French ANRS CO16 Lymphovir Cohort Study (2014) (1)
- Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients (2019) (1)
- Risk of HIV-associated Hodgkin lymphoma during the first months after initiation of combination antiretroviral therapy (2010) (1)
- P10-10 Comparaison de trois systèmes de recueil des cas de décès d’adultes infectés par le virus de l’immunodéficience humaine en France en 2000 (2004) (1)
- SARS CoV-2 Seroprevalence Among HIV-Negative Participants Using Tenofovir/Emtricitabine Based PrEP in 2020 – A Sub-study of ANRS PREVENIR and INSERM SAPRIS-Sero Cohorts (2022) (1)
- The calculated genetic barrier for drug resistance mutations in six different non-B subtypes and two CRFs in a large European dataset is largely similar to subtype B (2004) (1)
- Increased Production of B-Cell Activating Cytokines and Altered Peripheral B-Cell Subset Distribution during HIV-Related Classical Hodgkin Lymphoma (2021) (1)
- Description des causes de décès observés en France chez les personnes séropositives pour le VIH âgées de plus de 50 ans (2015) (1)
- Increased Risk of Severe COVID-19 in Hospitalized Patients With SARS-CoV-2 Variant of Concern Alpha Infection in France: A Multicentre Matched Cohort Study With Retrospective Data Collection (2021) (1)
- Atteintes démyélinisantes du système nerveux central et vaccination contre l’hépatite B : un nouvel épisode de l’interminable saga française ! (2008) (1)
- HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa (2016) (1)
- Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France (2018) (1)
- Characterization of viral rebounds on dual etravirine/raltegravir maintenance therapy (ANRS-163 ETRAL trial). (2020) (1)
- [A fighting life against AIDS]. (2008) (1)
- Abstract 15792: HIV-Infected Patients Have an Increased Risk of Recurrent Ischemic Events as Compared to the General Population After an Acute Coronary Syndrome (2011) (1)
- HIV incidence estimates among women of childbearing age in the area around Paris, France: no evidence for any effect of age or time. (2001) (1)
- [Central nervous system demyelinating events and hepatitis B vaccine: a new episode of the never ending French saga!]. (2008) (1)
- Early patient access to health technologies: Is innovation needed for early management? (2019) (1)
- Rôle de l’enveloppe GP 41 dans la préparation d’un candidat vaccin contre le VIH (2009) (1)
- 023 HIV-infected status is associated with increased recurrence of acute coronary syndrome. Results of long term follow up of the PACS-HIV study (2012) (1)
- Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among HIV-Negative Participants Using Tenofovir/Emtricitabine-Based Preexposure Prophylaxis in 2020: A Substudy of the French National Agency for Research on AIDS and Viral Hepatitis PREVENIR and Inserm SAPRIS-Sero Cohorts (2022) (1)
- [Is lung cancer screening by the helical scanner justified?]. (2007) (1)
- Demographics of HIV and aging opyright (2014) (1)
- A multifaceted intervention designed to improve medical management of moderate to advanced chronic kidney disease in HIV-infected patients: a cluster randomized trial. (2015) (1)
- Améliorer la prise en charge de l’insuffisance rénale chronique modérée à sévère chez les patients vivant avec le VIH en France : un essai en cluster (2014) (1)
- Responses in Humans Promotes Both CD 4 and CD 8 T Cell Immune Transcutaneous Anti-Influenza Vaccination (2008) (1)
- Comparison of HIV-Infected and Noninfected Patients Undergoing Bariatric Surgery: The ObeVIH Study (2022) (1)
- Use of rilpivirine in HIV-1-infected individuals in routine clinical practice from 2012 to 2017 in France. (2020) (1)
- Coronary Angiographic Features and Major Adverse Cardiac or Cerebrovascular Events in People Living With Human Immunodeficiency Virus Presenting With Acute Coronary Syndrome. (2022) (1)
- HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data) (2022) (1)
- TESTING FOR HUMAN IMMUNODEFICIENCY VIRUS P24 ANTIGEN. AUTHORS' REPLIES (1996) (1)
- Efficacy and Safety of Baricitinib for the Treatment of Hospitalized Adults with Severe or Critical COVID-19 (Bari-SolidAct): A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Trial (2022) (1)
- P643 Causes of liver related death in HIV-infected patients in France: mortality 2005 Survey (2007) (1)
- Factors influencing the incubation of an infectious form of Creutzfeldt-Jakob disease. (2019) (1)
- Chronic use of renin‐angiotensin‐aldosterone system blockers and mortality in COVID‐19: A multicenter prospective cohort and literature review (2021) (1)
- Données massives, vous avez dit données massives ? (2015) (1)
- Non-AIDS causes of death and immunodeficiency ( 40 characters ) (2012) (0)
- High Frequency of Marginal Zone Lymphomas Among Patients Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus - ANRS CO16 LYMPHOVIR Cohort Study (2010) (0)
- Immunological studies on the french cohort of 111 HIV-1 infected long-term non progressors (LT-NP) (1997) (0)
- Rates of viral suppression and regimen change according to initial HAART regimen: a collaborative analysis of 12 prospective cohort studies (2005) (0)
- AGE IN PEOPLE LIVING WITH HIV IN HIGH-INCOME COUNTRIES (2014) (0)
- Decrease in CD4 count and risk of severe morbidity in PWH with controlled viral load after initiating cART between 2006 and 2018. (2022) (0)
- 59.1. HIV-related neoplasms (2015) (0)
- Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance. (2023) (0)
- Implementation of a centralized pharmacovigilance system in academic pan‐European clinical trials: Experience from EU‐Response and conect4children consortia (2023) (0)
- Impact on renal function of daily and on-demand HIV pre-exposure prophylaxis in the ANRS-PREVENIR study. (2022) (0)
- Exploratory analysis for the development of a score-based interpretation system to predict abacavir susceptibility using the Forum for Collaborative HIV Research Database. (2006) (0)
- [Estimate of seroprevalence of HIV infection in Belgium using the back calculation method]. (1992) (0)
- Criteria foi Diagnosis of Right VeiMcular lschemia Associated With Inferior Wall Left Ventricular Acute Myocardial Infarction (1995) (0)
- HIV-associated tuberculosis: incidence trends and risk factors, France, 1997-2008. (2010) (0)
- Effect of interleukin 2 treatment on hepatitis B and C infections (2001) (0)
- Can HIV epidemics among men who have sex with men be eliminated through participation in PrEP rollouts? (2021) (0)
- Routine HIV screening in France: an estimation of clinical impact and cost-effectiveness. (2010) (0)
- P16-11. HLA-B57/5801 induces preferential CD27 expression on HIV-Gag but not Nef specific central memory CD8+T cells controlling HIV (2009) (0)
- [HIV-1 infection: how are long-term asymptomatic subjects characterized?]. (1995) (0)
- Altered Heterochromatin Organization after Perinatal Exposure to Zidovudine (2006) (0)
- [Cervical cancer: new testing strategies?]. (2008) (0)
- AMultifaceted Intervention Designed to Improve Medical Management of Moderate to Advanced Chronic Kidney Disease in HIV-Infected Patients: A Cluster Randomized Trial (2015) (0)
- Abstract 14435: Can Syntax Scores Predict Major Cardiac Events in People Living With Human Immunodeficiency Virus Presenting With Acute Coronary Syndrome? (2019) (0)
- Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE (2020) (0)
- Anticorps anticardiolipines, réplication virale, anticorps neutralisants et activation immune chez les patients VIH asymptomatiques à long terme (2009) (0)
- Les inhibiteurs du système rénine-angiotensine et la mortalité par COVID-19 : une cohorte prospective de 1160 patients hypertendus, et revue de littérature (2021) (0)
- Incidence o f N on-AIDS-Definin g C ancers B efore a nd D uring the H ighly A ctive A ntiretroviral T herapy E ra i n a C ohort o f Human I mmunodeficiency V irus-Infected P atients (2003) (0)
- Nutritional status of preschool age children from the northeast benue development project zone in northern cameroon (1987) (0)
- Iconography : Épidémiologie de l’infection à VIH en France et en Europe (2008) (0)
- Artésunate en France : 5 années de surveillance de son efficacité et de sa tolérance (2017) (0)
- N-03 Anticorps anticardiolipines, réplication virale, anticorps neutralisants et activation immune chez les patients VIH asymptomatiques à long terme (2008) (0)
- DOSSIER THÉMATIQUE : LE CANCER DU CANAL ANAL (2011) (0)
- Conséquences de l'utilisation des traitements antirétroviraux puissants sur l'épidémiologie des manifestations cliniques de l'infection à VIH (1999) (0)
- Risque d’infection bactérienne sévère chez les PVVIH à l’ère des cART (2020) (0)
- Pathologies malignes associées ou non à l'infection à VIH: interactions médicamenteuses entre chimiothérapies et anticancéreux (2009) (0)
- Causes de décès par hépatopathie en France en 2005 des adultes infectés par le VIH: enquête Mortavic 2005 en collaboration avec Mortalité 2005, ANRS-EN19 (2006) (0)
- Initiation tardive du traitement antirétroviral (CART) chez les hommes migrants originaires d’Afrique sub-saharienne et des Antilles non Françaises infectés par le VIH vivant en France comparé aux patients nés en France (2014) (0)
- Causes de décès chez les femmes infectées par le VIH en 2005 ; évolution depuis 2000 et comparaison aux hommes ; enquêtes mortalité 2000 et 2005 (ANRS EN19) (2008) (0)
- 536Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs) Comparing Initial Non-Nucleoside Reverse-Transcriptase Inhibitor (NNRTI)- versus Ritonavir Boosted Protease Inhibitor (PI/r)-based Anti-Retroviral Therapy (ART) (2014) (0)
- Causes de décès par cancer en France en 2005 des adultes infectés par le VIH: Enquête Mortalité 2005, ANRS-EN19, en collaboration avec Mortavic (2006) (0)
- Évolution de la survie après un cancer chez les personnes infectées par le VIH. Résultats de la cohorte FHDH-ANRS CO4 (2014) (0)
- Tumeurs malignes non opportunistes et infection à VIH (2005) (0)
- A4-5 Impact sur la survie de la prise en charge tardive des patients infectés par le virus de l’immunodéficience humaine à l’ère des thérapies antirétrovirales hautement actives (2004) (0)
- [Risk of the appearance of inhibitors linked to the administration of factors VIII and IX. Review of the literature]. (1994) (0)
- Potential impact of differences in frequency of minor substitutions between HIV-1 subtypes on the genetic barrier for resistance to protease inhibitors (2005) (0)
- Faut-il craindre une épidémie de grande taille pour le nouveau variant de la maladie de Creutzfeldt- Jakob ? (2007) (0)
- L'adaptation aux événements de la vie courante: sa mesure et son impact sur la santé. Revue concernant la période 1975-1978. (1980) (0)
- Iconography : Recommandations - Traitement médicamenteux de l’ostéoporose post-ménopausique (2008) (0)
- Facteurs de risque de dermatite séborrhéique : étude cas-témoins et cas-croisé. Étude EPIDERMAS (2014) (0)
- Incidence of second cancer among PLWHIV: A retrospective observational study of a series of 601 patients in the French CANCERVIH network (2019) (0)
- Risque d'apparition d'inhibiteurs liésà l'administration de facteurs VIII et IX Revue de littérature (1994) (0)
- [Not Available]. (2012) (0)
- Estimation de la séroprévalence de l'infection par le VIH en Belgique par la méthode de rétrocalcul (1992) (0)
- Cancer et VIH : actualités 2017 (2018) (0)
- La mise en place des cohortes en France : pourquoi, pour qui, comment et avec quels moyens ? (2012) (0)
- Impact des nouveaux antirétroviraux chez les patients infectés par le VIH en échec virologique (2012) (0)
- Quelle approche pour l’évaluation comparative en situation observationnelle : un exemple dans l’infection à VIH (2011) (0)
- [Not Available]. (2012) (0)
- Faisabilité d’appariement indirect entre la base hospitalière française sur l’infection à VIH et le Sniiram (2017) (0)
- Differences inandrogens ofHIVpositive patients withandwithout Kaposi sarcoma (2011) (0)
- Obésité chez les patients infectés par le VIH en France : prévalence et traitement chirurgical (2015) (0)
- Prévalence élevée des lymphomes de la zone marginale chez les patients co-infectés VIH-VHC à l’ère de la trithérapie anti-virale : cohorte ANRS CO16 Lymphovir (2010) (0)
- contemporary cohort of asymptomatic HIV-infected women (2015) (0)
- L'interprétation des tests génotypiques de résistance aux antirétroviraux (2001) (0)
- Causes de décès chez les femmes infectées par le VIH en 2005 : comparaison aux hommes et évolution depuis 2000 ; enquêtes « Mortalité 2000 et 2005 » (ANRS EN19) (2008) (0)
- SIDA, maladies associées : pistes pour de nouveaux médicaments (1996) (0)
- R-06: Aspergillose invasive (AI) chez les patients infectés par le VIH en France : évolution sur 20 ans (2014) (0)
- HIV‐related neoplasms (2017) (0)
- M-10 - Pneumocystose (PCP) en France à l’ère des combinaisons antirétrovirales (cART) : conséquence d’un diagnostic tardif ou d’un suivi irrégulier (2013) (0)
- [Insulin therapy in aged patients]. (1986) (0)
- [Multidiscipline aspects and approach to the evaluation of care for diabetics]. (1982) (0)
- International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
- International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
- [Diagnosis and evaluation of educational strategies for non-insulin-dependent diabetics and their treating physicians in France]. (1991) (0)
- Perception of PrEP-related stigma in PrEP users: Results from the ANRS-PREVENIR cohort. (2023) (0)
- 005 - ST-elevation myocardial infarction admission during "ON-" versus "OFF-" hours: is there an impact on outcome for primary PCI? (2011) (0)
- Liver steatosis and fibrosis in at-risk European HIV-monoinfected patients (2017) (0)
- O646 - Major histocompatibility gene frequencies in long term asymptomatic (LTA) HIV patients in France (1996) (0)
- Risk of Severe Bacterial Infection in People Living Human Immunodeficiency Virus Infection in the Combined Antiretroviral Therapy Era (2020) (0)
- [Towards a vaccine for HIV infection: role of the gp41 envelope protein]. (2009) (0)
- [Drug treatment of postmenopausal osteoporosis. What's New in 2006]. (2006) (0)
- Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: Results from the DREAM programme (p 452-458) (2005) (0)
- 19th International Workshop on HIV Observation Databases, Catania, Italy (2015) (0)
- Outcomes in antiretroviral-naive HIV-infected patients initiating therapy with TDF/FTC plus either atazanavir/r or another third recommended drug (2010) (0)
- Incidence of Kaposi's Sarcoma and survival following its diagnosis in HIV-infected homosexual men followed up since HIV seroconversion (2010) (0)
- Kaposi Sarcoma i ncidence and Survival Among H i V- i nfected Homosexual Men After H i V Seroconversion (2010) (0)
- Cannabis Use and Plasma Human Immunodeficiency Virus (HIV) RNA Levels in Patients Coinfected With HIV and Hepatitis C Virus Receiving Antiretroviral Therapy: Data From the ANRS CO13 HEPAVIH Cohort (2020) (0)
- Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort. (2023) (0)
- Inappropriate intensity statin therapy causing worse lipid profiles in HIV-infected individuals after acute coronary syndrome (2017) (0)
- Syphilis infection is associated with an increase in plasma viral load in HIV infected patients: results from the FHDH cohort — ANRS CO4 (2010) (0)
- AIDS 2002, Barcelona (2002) (0)
- Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
- Mortality rates according to initial HAART regimen: a collaborative analysis of 12 prospective cohort studies (2005) (0)
- Progression to AIDS in french haemophiliacs: Analysis of the association with HLA DR1 and DR5 (1996) (0)
- Is it necessary to conduct trials with trimethoprim-sulphamethoxazole amongst HIV-infected individuals in Africa? (1998) (0)
- Is impaired kidney function an independent predictor of the risk of myocardial infarction in HIV-infected individuals? (2014) (0)
- Mortality in HCV-cured versus HCV-uninfected people with HIV: a matched analysis in the ANRS CO4 FHDH cohort. (2023) (0)
- Coinfection with HCV or HBV Increases the Risk of Lymphoma in HIV-Positive Patients: A Combined Analysis of the Lymphovir-ANRS-CO16 and Fhdh-ANRS-CO4 Cohorts (2017) (0)
- CD4:CD8 ratio and CD8 count as prognostic markers for mortality in HIV-positive patients on ART (2017) (0)
- [Can a large epidemic for the new variant of Creutzfeldt-Jakob disease be feared?]. (2007) (0)
- [Adaptation to life events: its measure and effect upon health. A review from 1975 to 1978 (author's transl)]. (1980) (0)
- Tackling latency as a barrier to an HIV cure: what next? (2015) (0)
- HIV positive men with Kaposi sarcoma trogens in male HIV positive patients with and without Kaposi sarcoma and in HIV negative men (0)
- [Do simple sugars have a place in the diabetic diet?]. (1985) (0)
- Modeling remdesivir antiviral efficacy in COVID-19 hospitalized patients of the randomized, controlled, open-label DisCoVeRy trial (2021) (0)
- Is statin preventing cancer in HIV-1 infected individuals? An inappropriate methodology is a more likely explanation. (2015) (0)
- Risk of severe bacterial infection in people living with HIV infection in the cART era. (2020) (0)
- [Impact of new antiretroviral therapy in HIV infected patients with virologic failure]. (2012) (0)
- Impact of etravirine use on hospitalization rates among highly pre-treated failing HIV-1 infected individuals between 2005 and 2011 (2014) (0)
- Effects of Remdesivir in Hospitalized Patients with COVID-19: Systematic Review and Individual Patient Data Meta-Analysis of Randomized Clinical Trials (2022) (0)
- Initiatives for developing genotype interpretation systems: derivation and validation of a didanosine interpretation system using large derivation and large validation datasets (2008) (0)
- Abstract 17534: HIV-Infected Patients Exhibit a Worse Cardiovascular Risk Profile After a First Episode of Acute Coronary Syndrome (2011) (0)
- Effects of rosuvastatin and pravastatin on high-density lipoprotein subfractions in HIV-1-infected patients receiving protease inhibitors (2014) (0)
- Effect ofinterferon on high serum androgen concentrations inHIVpositive men withKaposi's (1997) (0)
- The socio-demographic, clinical characteristics and outcomes of tuberculosis among HIV infected adults in Lithuania: A thirteen-year analysis (2023) (0)
- What about primary pulmonary hypertension in HIV infection in the era of combination antiretroviral therapy? (2008) (0)
- [Is insulin-treated diabetes a cause for institutionalization after age 70?]. (1986) (0)
- What is the better prognostic marker – CD8 or CD4:CD8 ratio? (2015) (0)
- CP-142 Antiretroviral therapy optimisation in multitreated hiv patients: clinical and pharmacoeconomic approach in the ecovir study (2017) (0)
- Validation of molecular indicators of resistance transmission (MIRTs) for epidemiological studies of drug resistance transmission in HIV (2004) (0)
- Characteristics and Outcome Among 116 Patients with HIV Associated Lymphoma Included in the French ANRS CO16 Lymphovir Cohort Study. (2012) (0)
- Mortality declined substantially between 1996-2010 among patients starting ART (2015) (0)
- Higher Mortality in People Living with HIV after Cure of Hepatitis C by Direct-Acting Antivirals Compared to Those Without Hepatitis C: Results from the ANRS CO4 FHDH Cohort (2022) (0)
- Is The Age-Period-Cohort Model Well Suited to an Epidemic Context? The Case of the French BSE Epidemic (2012) (0)
- Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH) (2022) (0)
- Testing for human immunodeficiency virus p24 antigen (1996) (0)
- Sterne, J. A. C. (2020). Cause-specific mortality after diagnosis of cancer among HIV-positive patients: a collaborative analysis of cohort (2020) (0)
- [Nursing surveillance during antitubercular drug treatment]. (2006) (0)
- Author’s reply (2002) (0)
- PREDICTIVE FACTORS FOR DISEASE PROGRESSION AND DEATH IN AIDS RELATED KAPOSI'S SARCOMA. (1999) (0)
- Coronary Heart Disease in HIV-Infected Patients: Epidemiology (2009) (0)
- ZIDOVUDINE IN PATIENTS WITH HIV INFECTION. AUTHORS' REPLY (1996) (0)
This paper list is powered by the following services:
Other Resources About Dominique Costagliola
What Schools Are Affiliated With Dominique Costagliola?
Dominique Costagliola is affiliated with the following schools:
